Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-05-02

Clinical Trial Update: Reduced Intensity Conditioning Before Partially Matched Donor Stem Cell Transplant in Treating Patients With Advanced Cutaneous T Cell Lymphoma [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating reduced-intensity conditioning before a partially matched donor stem cell transplant for advanced cutaneous T-cell lymphoma has been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Cutaneous T-Cell Non-Hodgkin Lymphoma, Recurrent Mycosis Fungoides and Sezary Syndrome | Phase 1 | Status: WITHDRAWN